Gigantic primary melanomas represent a rare clinical finding. Large Melanomas have usually a poor prognosis because of a high risk of extensive metastatic disease at the diagnosis. Six other cases only of primary gigantic melanoma without regional or systemic metastases have been described in medical literature. A 90-year-old woman presented to our Plastic Surgery Department with a six years history of a 13.2 × 12.0 cm melanoma growing on her left cheek. No metastasis has been described by CT or PET. This gigantic melanoma of the cheek demonstrated to be only locally aggressive. A wide excision appeared to be resolutive to the histological and immunostain (Melan-A, S-100) analysis.
Introduction
Gigantic primary melanoma is a rare observation in clinical practice. Few cases have been reported in medical literature. Large melanomas generally have a poor prognosis because of the high risk of extensive metastatic disease at the diagnosis [1] . According to our literature review six other cases only of primary giant melanoma without regional or systemic metastases have been described and only one of these deals with the facial region [2] . Moreover this clinical case demonstrated an unconventional clinical behavior of the gigantic melanoma which was remarkable to be described.
Case Report
A 90-year-old woman presented to our Plastic Surgery Department with a six years history of an asymptomatic growth on her left cheek (Figure 1 ). She and her family neglected the problem because of the patient's elderly age until the mass began to be a severe problem for her and her family, impeding opening her mouth and chewing. Objective structured clinical examination revealed a 13.2 × 12.0 cm malodorous, brown, firm, vegetative mass with necrotic areas covered by purulent exudation. No palpable regional lymph node was identified. Two homolateral laterocervical lymph nodes were enlarged and elastic to palpation. Serum lactate dehydrogenase level was normal.
Total-body positron emission tomography ( Figure 2 ) and computed tomography scan showed no evidence for metastatic disease. Reconstruction was performed with a Bakamjian deltopectoral flap and a split-thickness skin graft (Figure-4 ). Histological examination of the surgical excision revealed a nodular proliferation of atypical and epithelioid melanocytes positive for Mart-1 and S-100 immunostains. Breslow's depth was 9 cm, Clark level was V, ulceration was positive in some focal areas, and there was no regression signs. All the excisional margins have been histologically tested negative for tumour infiltration by direct microscopic observation and Melan-A, S-100 immunostains. Four mitoses/mm2 were identified.
There was no evidence of vascular invasion. One regional lymph node was included in the tumour and macroscopically invaded. The excised homolateral cervical lymph nodes were negative for metastasis by microscopic and immunostains testing.
According to the AJCC TNM staging system, the patient was classified as stage III C disease (pT4b, N1b, M0). Post-operative Total-body positron emission tomography PET and follow-up computed tomography scan confirmed no evidence for metastatic disease.
The patient declined chemotherapy because of her elderly age according with the oncologist. At 6 months' follow-up, the patient was disease free with no clinical evidence of local or distant signs of recurrence. No long term follow up has been possible due to very low rate patient compliance.
Discussion
Few cases of gigantic melanoma have been reported in medical literature. According to the reviewed literature on this topic (Di Meo and associates, and Chong and associates) six others published cases only did not have metastatic disease at the diagnosis [2, 3] . Melanoma classification is inflexibly changing course to reclassify melanoma subtypes based on genetic profile. This trend may predict pathologic behavior and outcomes more accurately than actual histopathologic features.4
In the case described, this gigantic melanoma of the cheek was demonstrated to be only locally aggressive, and a wide excision appeared to be the ideal and more effective treatment. Moreover, in this and in all the reviewed cases, the presence of many negative prognostic factors (Breslow's depth, size, exophytic growth, ulceration) did not directly correlate to objective distant aggressiveness or poor outcome and prognosis, as usually happened for smaller conventional nodular melanomas [2-4].
There are not enough data to review classification; anyway thee unconventional cases may suggest the existence of gigantic melanomas typical features. For this reason we consider important to share clinical experiences updating information to identify distinct genetic subtypes correlate to gigantic melanoma that, while locally aggressive, appears to lack a propensity for systemic metastatization and gives a much better prognosis despite a terrific clinical presentation.
